Not because the product's wrong. Healthcare just doesn't buy like other markets:
We've sold the hard stuff, into clinics and the Fortune 500. We book the revenue before your runway runs out.
Free 30-min audit. Leave with a committee map and a 90-day plan, yours to keep whether we work together or not.
Six walls between you and a signed deal ↓
Clinical, IT, security, finance, procurement. A one-persona pitch dies in committee.
No ROI instrument, no purchase order. "Interesting" is where deals go to die.
Can't speak to Epic, Cerner or athenahealth? The call ends before value comes up.
Deals run 2–4 quarters. You burn runway chasing them the wrong way.
They sell traffic and vanity metrics. Your buyer needs clinical proof and economics.
SOC 2 and HIPAA show up in the first diligence pass now, not the last.
Before we send a single message, we research your market the way your buying committee and your competitors do, then hand you a diagnostic with prioritized fixes and a 90-day plan.
You keep the diagnostic and the 90-day plan to first signed revenue, whether or not we work together.
You've paid a generalist or offshore lead-gen shop that didn't understand healthcare.
Drained budget, quiet calendar.
We're the senior, healthcare-native alternative. We've sold the hard stuff.
We fix what they broke and build the engine that should've been there from the start.
I'm not an agency that runs campaigns from a dashboard. I'm the operator who's actually sold the hard stuff:
Structural engineering at Waterloo, an Engineer Officer in the Canadian Armed Forces, then I built Bitlab's healthcare go-to-market engine from zero. Because LeadsACE partners with Bitlab, when you need the product built too, not just marketed, we bring real engineering to the table. No other growth agency can say that.
No pipeline. No brand. A skeptical market. A product still being built. We led with loss-aversion math, not features, and signed 12 clinics before the product even worked.
First dedicated salesperson. Landed and expanded a global software account into a 280-seat deal, then trained ~500 users across 7–8 regional orgs. Training is why the seats renewed.
It's almost triple the benchmark I've been told for our industry.Christopher Leidli · CEO
Idea to a working product in under two months, after two agencies failed. Then the ongoing growth engine across SEO, Meta and Google ads, and content, drawing global pharma interest.
Read the full case study →
We assemble the right machines for your motion. Click any for the full breakdown.
Three models sold under one word — and when you shouldn’t hire us.
An operator’s honest map of the five agency archetypes — and where we fit.
One message every veto-holder hears as their own win.
× Kills: the demo that goes nowhereA managed fleet of sender profiles, specialty-tailored sequences.
× Kills: an empty top of funnelDeliverability-first, so your message lands in the inbox.
× Kills: outreach nobody seesThe revenue system everything runs on, migrated clean.
× Kills: deals you can't forecastEvery lead worked, on time, without new headcount.
× Kills: the #1 leak, slow follow-upYour team runs the motion, so the renewals last.
× Kills: a pipeline that dies when we leavePick your product category for B2B benchmark defaults, then tune to your motion — drag a slider or click any number to type it. The pipeline math: budget → leads → demos → closed deals → new ARR.
Same engine, three ways to deploy it. Built for the clock you're racing: traction before the raise, not after.
We build the machine that survives a clinical buying committee, then hand your team the keys.
Everything in Growth Systems, plus we operate it. Booked demos with the right buyers, every week.
Everything in Fractional Growth Lead, plus a dedicated team executing across every channel at volume.
You've been burned before. So we don't ask you to bet the budget on a promise.
Qualified conversations start within weeks of going live, and booked, revenue-generating meetings inside the first 90 days. We've generated 20+ qualified leads in a single week from outbound alone, with no ad budget.
Yes — that's the wedge. Healthcare doesn't buy from one person; it buys from a committee of clinical, IT, finance and compliance stakeholders, each with a different veto. We've sold AI into clinics and SaaS into the Fortune 500, and we sell to that committee rather than around it.
Founders start with a scoped 30-day pilot. If the pipeline isn't taking shape, you walk — there's no commitment past the pilot. We'd rather prove it than sell you a retainer.
Neither. An agency markets and a fractional CMO advises; we build the engine, work the pipeline and book the meetings. As Dripify's first salesperson we built the enterprise motion from scratch — 160+ accounts and 850+ enterprise seats across the Fortune 500.
Because generalists don't know your buyer, your compliance reality or your sales cycle, so they optimise for volume you can't close. We took Voxira from a cold start to 150+ qualified leads, 12 signed clinics and a $6.2M Series A.
From the playbook